Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
7.11
-0.10 (-1.39%)
Dec 12, 2025, 4:00 PM EST - Market closed
Exagen Market Cap
Exagen has a market cap or net worth of $161.13 million as of December 15, 2025. Its market cap has increased by 131.88% in one year.
Market Cap
161.13M
Enterprise Value
153.65M
1-Year Change
131.88%
Ranking
Category
Stock Price
$7.11
Market Cap Chart
Since September 19, 2019, Exagen's market cap has increased from $63.11M to $161.13M, an increase of 155.34%. That is a compound annual growth rate of 16.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 161.13M | 122.83% |
| Dec 31, 2024 | 72.31M | 113.18% |
| Dec 29, 2023 | 33.92M | -13.39% |
| Dec 30, 2022 | 39.17M | -79.17% |
| Dec 31, 2021 | 187.99M | 12.56% |
| Dec 31, 2020 | 167.01M | -47.65% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 920.02B |
| Johnson & Johnson | 509.76B |
| AbbVie | 394.69B |
| UnitedHealth Group | 309.65B |
| AstraZeneca | 278.45B |
| Novartis AG | 254.39B |
| Merck & Co. | 248.95B |
| Novo Nordisk | 224.22B |